Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50.
- DOI
- 10.3389/fimmu.2024.1348034
- Published
- 2024-02-23
- Container
- Front Immunol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2024.1348034,
title = {Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50.},
author = {Takei S and Kawachi H and Yamada T and Tamiya M and Negi Y and Goto Y and Nakao A and Shiotsu S and Tanimura K and Takeda T and Okada A and Harada T and Date K and Chihara Y and Hasegawa I and Tamiya N and Katayama Y and Nishioka N and Morimoto K and Iwasaku M and Tokuda S and Kijima T and Takayama K.},
year = {2024},
journal = {Front Immunol},
doi = {10.3389/fimmu.2024.1348034},
url = {https://doi.org/10.3389/fimmu.2024.1348034}
}RIS
TY - JOUR TI - Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50. AU - Takei S AU - Kawachi H AU - Yamada T AU - Tamiya M AU - Negi Y AU - Goto Y AU - Nakao A AU - Shiotsu S AU - Tanimura K AU - Takeda T AU - Okada A AU - Harada T AU - Date K AU - Chihara Y AU - Hasegawa I AU - Tamiya N AU - Katayama Y AU - Nishioka N AU - Morimoto K AU - Iwasaku M AU - Tokuda S AU - Kijima T AU - Takayama K. PY - 2024 JO - Front Immunol DO - 10.3389/fimmu.2024.1348034 UR - https://doi.org/10.3389/fimmu.2024.1348034 ER -
APA
S, T., H, K., T, Y., M, T., Y, N., Y, G., A, N., S, S., K, T., T, T., A, O., T, H., K, D., Y, C., I, H., N, T., Y, K., N, N., K, M., M, I., S, T., T, K., & K., T. (2024). Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50.. Front Immunol. https://doi.org/10.3389/fimmu.2024.1348034
Source records
- europe-pmc · retrieved 2026-09-26T17:09:42.085Z
- doaj · retrieved 2026-09-26T17:09:42.073Z